In the BioHarmony Drug Report Database

"Preview" Icon

Disopyramide

Norpace (disopyramide) is a small molecule pharmaceutical. Disopyramide was first approved as Norpace on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, cardiac arrhythmias, and ventricular premature complexes in the USA. It is known to target potassium voltage-gated channel subfamily H member 2 and alpha-1-acid glycoprotein 2.

 

Trade Name

 

Norpace
 

Common Name

 

disopyramide
 

ChEMBL ID

 

CHEMBL517
 

Indication

 

atrial fibrillation, atrial flutter, cardiac arrhythmias, ventricular premature complexes
 

Drug Class

 

Image (chem structure or protein)

Disopyramide structure rendering